Healthcare
STERIS plc(STE)
Live Price
Offline$207.56
+0.16% today
1Y Change
-12.62%
Window
Jun 20, 2025 โ Jun 15, 2026
- Market Cap
- $21.04B
- Revenue Growth
- +6.2%
- EPS Growth
- +62.9%
- Dividend Yield
- 1.1%
Coverage: 247 bars ยท Jun 20, 2025 โ Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
STERIS plc (STE) is a Healthcare stock with a market cap of $21.04B and listed on NYSE. The stock last traded around $207.56 and down 12.6% across the available one-year price window (Jun 20, 2025 โ Jun 15, 2026). Baseline metrics include revenue growth of +6.2%, EPS growth of +62.9%, a dividend yield of 1.1%. What stands out right now is revenue +6.2%, EPS +62.9%, free cash flow +26.9% with operating margin 17.2% and ROIC 7.8%. The dividend is present but secondary, with a yield around 1.1%. Valuation is more restrained than many high-expectation growth names at P/E 29.8 and price/sales 3.6. Stock Foundry combines STE price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Near sector median
+6.2% vs +7.6% peer median
Operating Margin
Below sector median
+17.2% vs +19.4% peer median
P/E
Below sector median
29.8 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 13, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +6.2% and EPS at +62.9%, with operating margin around 17.2%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 1.1%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +1.5% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 13, 2026 | โ | +2.3% | +2.3% | -1.8% |
2026 Feb 4, 2026 | +0.0% | -7.7% | -7.9% | -9.7% |
2025 Nov 5, 2025 | +5.1% | +6.9% | +10.2% | +7.3% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
STE
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
STE Max Drawdown
-24.87%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for STE and SPY.
Company Overview
STERIS plc
New York Stock Exchange
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
- Leadership
- Daniel A. Carestio
- IPO Date
- Jun 1, 1992
- Employees
- 18.0k
- Street Address
- 70 Sir John Rogerson's Quay
- Mailing
- Dublin, D02 R296
- Region
- Dublin, IE
- Reporting Currency
- USD
- Investor Line
- 353 1 232 2000
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 29.8
- EV/EBITDA
- 16.6
- Price/Sales
- 3.6
- Price/Book
- 2.9
Growth
- Revenue
- +6.2%
- EPS
- +62.9%
- Free Cash Flow
- +26.9%
Profitability
- Gross Margin
- 44.1%
- Operating Margin
- 17.2%
- Net Margin
- 12.1%
- ROE
- 10.2%
- ROIC
- 7.8%
Balance Sheet
- Debt/Equity
- 0.29
- Current Ratio
- 2.48
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.